Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/KCT0002920
KCT0002920Completed未知

Pragmatic Trial Comparing Symptom-Oriented Versus Routine Stress Testing in High-Risk Patients Undergoing Percutaneous Coronary Intervention

Asan Medical Center0 sites1,707 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Enrollment
1,707
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

we found no significant between-group difference in the primary composite outcome of death, myocardial infarction, or hospitalization for unstable angina at 2 years.

Study Design

Study Type
Interventional Study

Eligibility Criteria

Ages
19(Year) to 0No Limit (—)
Sex
All

Inclusion Criteria

  • •Subject was > 19 years of age.
  • •Subjects who underwent successful PCI with contemporary drug eluting stent or contemporary bioresorbable vascular scaffold.
  • •Patients must have at least one of the following high-risk clinical, lesion, or procedure-related risk factors.
  • •3-1. Clinical factors; diabetes, renal insufficiency/failure, enzyme positive acute coronary syndrome (ACS) (STEMI or NSTEMI).
  • •3-2. Lesion- or procedure-related factors ; left main lesion, bifurcation lesion, ostial lesion, chronic total occlusion lesion, multivessel disease (= 2 vessels stented), restenotic lesion, diffuse long lesion (lesion length =30 mm or stent length =32 mm), or vein bypass graft stented
  • •The patient or guardian agrees to the study protocol and the schedule of clinical follow-up, and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethical Committee of the respective clinical site.

Exclusion Criteria

  • •Cardiogenic shock at the index admission
  • •Subject treated with only bare metal stent or balloon angioplasty during the index procedure.
  • •Pregnant and/or lactating women.
  • •Concurrent medical condition with a life expectancy of less than 1 years
  • •Patients who are actively participating in another drug or device investigational study, which have not completed the primary endpoint follow-up period.
  • •6 Subject was unable to provide written informed consent or participate in long-term follow-up.

Investigators

Similar Trials

Not yet recruiting
Not Applicable
Comparative trial of the impact of patient-specific 3D virtual and printed 3D liver models compared to standard computed tomography on anatomical comprehension and surgical planning - A prospective, three-armed, randomized trialPatients undergoing liver resection of a tumour.
DRKS00031987niversitätsklinikum Carl Gustav Carus78
Completed
Not Applicable
Comparison of Clinical outcomes and complications of bilateral knee joint replacement simultaneously and after 48 hoursknee joint.
IRCT20190127042514N6Kerman University of Medical Sciences100
Not yet recruiting
Not Applicable
Comparison of visual outcomes ,patient satisfaction following bilateral insertion of Tecnis Synergy versus PanOptix trifocal intraocular lenses
CTRI/2021/11/038106johnson and johnson
Active, not recruiting
Not Applicable
A study to compare the effectiveness and morbidity of Alkalinized Intravesical Lidocaine Vs Lidocaine gel in achieving anaesthesia prior to intravesical Botulinum Toxin (BTX) injectionsThe aim of this randomised study is to compare the effectiveness and morbidity of alkalinized intravesical Lidocaine Vs Lidocaine gel in achieving adequate anaesthesia prior to intravesical injections of Botulinum Toxin (BTX).
EUCTR2010-018611-15-GBAbertawe Bro Morgannwg University LHB
Not yet recruiting
Phase 4
Ayurvedic Treatment for Oral Submucosal Fibrosis
CTRI/2023/03/050422Department of Shalakya tantra